Literature DB >> 21467850

F-18 FDG uptake patterns and disease activity of collagen vascular diseases-associated arthritis.

Tetsuhiko Okabe1, Hirofumi Shibata, Kazuya Shizukuishi, Tomohiro Yoneyama, Tomio Inoue, Ukihide Tateishi.   

Abstract

PURPOSE: The purpose of the present study was to investigate F-18 FDG uptake patterns, and to see whether joint F-18 FDG uptake reflected disease activity in patients with collagen vascular diseases (CVD)-associated arthritis.
MATERIALS AND METHODS: A total of 72 patients with CVD-associated arthritis and 30 control subjects who underwent F-18 FDG PET or PET/CT were retrospectively investigated. PET images of 12 major joints, 7 minor joints, and extra-articular accumulation were assessed. We investigated F-18 FDG uptake patterns and the relationships between the degree of F-18 FDG uptake and distribution, clinical symptoms, and laboratory test results.
RESULTS: Remitting seronegative symmetric synovitis with pitting edema syndrome, mixed connective tissue disease, rheumatoid arthritis, and systemic sclerosis tended to show strong and multiple joint F-18 FDG uptake. F-18 FDG uptake was found in bone marrow (86%) and/or spleen (57%) in 7 patients with adult-onset Still disease. The maximum standardized uptake value (SUVmax) correlated with the counts of erythrocyte sedimentation rate, matrix metalloproteinase-3, IgG, and IgA. Joint swelling had a positive association with SUVmax. Multiple logistic regression analyses revealed that factor associated with increased SUVmax of the joint was joint swelling (P = 0.005).
CONCLUSIONS: The degree of joint F-18 FDG uptake may contribute to predict active inflammatory process of the joint. In addition, F-18 FDG uptake patterns may have a potential which helps differential diagnosis of CVD-associated arthritis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467850     DOI: 10.1097/RLU.0b013e318212c858

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  6 in total

1.  Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors.

Authors:  Ubaldo E Martinez-Outschoorn; Zhao Lin; Casey Trimmer; Neal Flomenberg; Chenguang Wang; Stephanos Pavlides; Richard G Pestell; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

2.  Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.

Authors:  Denis Peruzzo; Marco Castellaro; Massimiliano Calabrese; Elisa Veronese; Francesca Rinaldi; Valentina Bernardi; Alice Favaretto; Paolo Gallo; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

3.  Increased 18F-FDG uptake suggests synovial inflammatory reaction with osteoarthritis: preliminary in-vivo results in humans.

Authors:  Molly A Parsons; Mateen Moghbel; Babak Saboury; Drew A Torigian; Thomas J Werner; Domenico Rubello; Sandip Basu; Abass Alavi
Journal:  Nucl Med Commun       Date:  2015-12       Impact factor: 1.690

Review 4.  Clinical value of whole-body PET/CT in patients with active rheumatic diseases.

Authors:  Hiroyuki Yamashita; Kazuo Kubota; Akio Mimori
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

5.  Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis.

Authors:  Anu Bhattarai; Takahito Nakajima; Santosh Sapkota; Yukiko Arisaka; Azusa Tokue; Yukio Yonemoto; Yoshito Tsushima
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

6.  Imaging and Methotrexate Response Monitoring of Systemic Inflammation in Arthritic Rats Employing the Macrophage PET Tracer [18F]Fluoro-PEG-Folate.

Authors:  Durga M S H Chandrupatla; Gerrit Jansen; Elise Mantel; Philip S Low; Takami Matsuyama; René P Musters; Albert D Windhorst; Adriaan A Lammertsma; Carla F M Molthoff; Conny J van der Laken
Journal:  Contrast Media Mol Imaging       Date:  2018-02-21       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.